Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Women’s Health Director Resigns Over Plan B

This article was originally published in The Pink Sheet Daily

Executive Summary

Susan Wood says she can “no longer serve as staff when scientific and clinical evidence...has been overruled.”

You may also be interested in...



Office Of Women's Health Gets Permanent Director

Kathleen Uhl, team leader for the Pregnancy & Lactation Labeling Team, will replace Susan Wood.

Office Of Women's Health Gets Permanent Director

Kathleen Uhl, team leader for the Pregnancy & Lactation Labeling Team, will replace Susan Wood.

NDAC Member Resigns Over Plan B, Rallies Fellow Panelists To Action

Former panel member and consultant says he will pursue options such as organizing a group letter to a medical journal from advisory committee members protesting FDA’s postponement of the Plan B decision.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS062818

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel